New York federal appeals court rules ‘pharma bro’, 40, who went to prison for fraud, cannot return to pharmaceutical industry
Martin Shkreli, the “pharma bro” entrepreneur who astronomically increased the price of a life-saving drug by more than 4,000% and became a symbol of corporate Wall Street greed, cannot return to the pharmaceutical industry, a court has ruled.
A federal appeals court in New York upheld his lifetime ban from the business.
More Stories
Qantas posts $1.39bn profit as holidaymakers flock to Jetstar
Chinese fishing fleets using North Korean forced labour in potential breach of sanctions, report claims
Trump’s threatened 25% tariffs on EU imports could trigger ‘economic turmoil’